Stocks and Investing
Stocks and Investing
Mon, October 11, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, October 10, 2021
[ 12:00 AM ] - WOPRAI
Fri, October 8, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Benjamin Burnett Downgraded (ALLO) to Hold on, Oct 8th, 2021
Benjamin Burnett of Stifel, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Hold on, Oct 8th, 2021.
Benjamin has made no other calls on ALLO in the last 4 months.
There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, 0 agree with Benjamin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Benjamin
- Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $36 on, Friday, September 24th, 2021
Contributing Sources